Jpmorgan Chase & CO Assertio Holdings, Inc. Transaction History
Jpmorgan Chase & CO
- $1.14 Trillion
- Q2 2024
A detailed history of Jpmorgan Chase & CO transactions in Assertio Holdings, Inc. stock. As of the latest transaction made, Jpmorgan Chase & CO holds 14,614 shares of ASRT stock, worth $17,829. This represents 0.0% of its overall portfolio holdings.
Number of Shares
14,614
Previous 40,575
63.98%
Holding current value
$17,829
Previous $38,000
52.63%
% of portfolio
0.0%
Previous 0.0%
Shares
9 transactions
Others Institutions Holding ASRT
# of Institutions
114Shares Held
37.2MCall Options Held
755KPut Options Held
39.5K-
Nantahala Capital Management, LLC New Canaan, CT9.27MShares$11.3 Million0.77% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.47MShares$5.45 Million0.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny2.38MShares$2.9 Million0.01% of portfolio
-
Aqr Capital Management LLC Greenwich, CT2.31MShares$2.82 Million0.0% of portfolio
-
Russell Investments Group, Ltd.2.2MShares$2.68 Million0.0% of portfolio
About Assertio Holdings, Inc.
- Ticker ASRT
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 48,178,200
- Market Cap $58.8M
- Description
- Assertio Holdings, Inc., a specialty pharmaceutical company, provides medicines in the areas of neurology, hospital, and pain and inflammation. Its pharmaceutical products include INDOCIN, an oral solution and a suppository form for the treatment of moderate to severe rheumatoid arthritis, including acute flares of chronic disease; ankylosing sp...